Log in with your email address username.

×

Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Better and safer treatment for multidrug-resistant tuberculosis

From a patient’s point of view, treatment of multidrug-resistant tuberculosis has advanced very little in the past 40 years. A long and difficult course of treatment, even when successful, usually means episodes of serious or life-threatening side-effects or disease complications. Patients who push through are not guaranteed a cure. Some who do survive are left with permanent disability.

email